HY-100131-1mL
|
MedChemexpress LLC
|
GSK481 [CAS 1622849-58-4] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-13928-10mg
|
MedChemexpress LLC
|
GW0742 [CAS 317318-84-6]
|
|
Cancer-Kinase/protease
|
|
HY-13928-100mg
|
MedChemexpress LLC
|
GW0742 [CAS 317318-84-6]
|
|
Cancer-Kinase/protease
|
|
HY-13928-5mg
|
MedChemexpress LLC
|
GW0742 [CAS 317318-84-6]
|
|
Cancer-Kinase/protease
|
|
HY-13928-50mg
|
MedChemexpress LLC
|
GW0742 [CAS 317318-84-6]
|
|
Cancer-Kinase/protease
|
|
HY-13928-1mL
|
MedChemexpress LLC
|
GW0742 [CAS 317318-84-6] (10mM in DMSO)
|
|
Cancer-Kinase/protease
|
|
HY-103428-10mg
|
MedChemexpress LLC
|
LE 300 [CAS 274694-98-3]
|
|
Neuroscience-Neuromodulation
|
|
HY-131034-10mg
|
MedChemexpress LLC
|
LP-922056 [CAS 1365060-22-5]
|
|
Cancer-programmed cell death
|
|
HY-131034-100mg
|
MedChemexpress LLC
|
LP-922056 [CAS 1365060-22-5]
|
|
Cancer-programmed cell death
|
|
HY-131034-25mg
|
MedChemexpress LLC
|
LP-922056 [CAS 1365060-22-5]
|
|
Cancer-programmed cell death
|
|
HY-131034-5mg
|
MedChemexpress LLC
|
LP-922056 [CAS 1365060-22-5]
|
|
Cancer-programmed cell death
|
|
HY-131034-50mg
|
MedChemexpress LLC
|
LP-922056 [CAS 1365060-22-5]
|
|
Cancer-programmed cell death
|
|
HY-131034-1mL
|
MedChemexpress LLC
|
LP-922056 [CAS 1365060-22-5] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-153612-1mg
|
MedChemexpress LLC
|
MMV009085 [CAS 298217-59-1]
|
|
|
|
HY-153612-10mg
|
MedChemexpress LLC
|
MMV009085 [CAS 298217-59-1]
|
|
|
|
HY-153612-5mg
|
MedChemexpress LLC
|
MMV009085 [CAS 298217-59-1]
|
|
|
|